Bidell Monique R, Opraseuth Melissa Palchak, Yoon Min, Mohr John, Lodise Thomas P
Albany College of Pharmacy and Health Sciences, 106 New Scotland Avenue, Albany, 12208-3492, NY, USA.
Merck & Co., Inc., Kenilworth, NJ, USA.
BMC Infect Dis. 2017 Feb 28;17(1):176. doi: 10.1186/s12879-017-2270-7.
This retrospective cohort study characterized the impact of prior antibiotic exposure on distribution and nonsusceptibility profiles of Gram-negative pathogens causing hospital-onset urinary tract infections (UTI).
Hospital patients with positive urine culture for Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and other Enterobacteriaceae ≥3 days after hospital admission were included. Assessment outcomes included the distribution of bacteria in urine cultures, antibiotic susceptibility patterns, and the effect of prior antibiotic exposure, defined as 0, 1, or ≥2 prior antibiotics, on the distribution and antibiotic susceptibility profiles of the Gram-negative organisms.
The most commonly isolated pathogens from 5574 unique UTI episodes (2027 with and 3547 without prior antibiotic exposure) were E. coli (49.5%), K. pneumoniae (17.1%), and P. aeruginosa (8.2%). P. aeruginosa was significantly more commonly isolated in patients with ≥2 prior antibiotic exposures (12.6%) compared with no exposure (8.2%; p = 0.036) or 1 prior exposure (7.9%; p = 0.025). Two or more prior antibiotic exposures were associated with slightly higher incidences of fluoroquinolone nonsusceptibility, multidrug resistance, and extended-spectrum β-lactamase phenotype compared with 0 or 1 exposure, suggesting an increased risk for resistant Gram-negative pathogens among hospital patients with urinary tract infections occurring ≥3 days after admission.
Clinicians should critically assess prior antibiotic exposure when selecting empirical therapy for patients with hospital-onset urinary tract infections caused by Gram-negative pathogens.
这项回顾性队列研究描述了既往抗生素暴露对导致医院获得性尿路感染(UTI)的革兰氏阴性病原体的分布和非敏感性谱的影响。
纳入入院≥3天后尿培养铜绿假单胞菌、大肠埃希菌、肺炎克雷伯菌和其他肠杆菌科细菌阳性的住院患者。评估结果包括尿培养中细菌的分布、抗生素敏感性模式,以及既往抗生素暴露(定义为0、1或≥2种既往使用的抗生素)对革兰氏阴性菌的分布和抗生素敏感性谱的影响。
在5574例独特的尿路感染发作中(2027例有既往抗生素暴露,3547例无既往抗生素暴露),最常分离出的病原体是大肠埃希菌(49.5%)、肺炎克雷伯菌(17.1%)和铜绿假单胞菌(8.2%)。与无既往抗生素暴露(8.2%;p = 0.036)或有1次既往抗生素暴露(7.9%;p = 0.025)的患者相比,有≥2次既往抗生素暴露的患者中铜绿假单胞菌的分离率显著更高(12.6%)。与0次或1次暴露相比,2次或更多次既往抗生素暴露与氟喹诺酮不敏感性、多重耐药性和超广谱β-内酰胺酶表型的发生率略高相关,这表明入院≥3天后发生尿路感染的住院患者中革兰氏阴性耐药病原体的风险增加。
对于由革兰氏阴性病原体引起的医院获得性尿路感染患者,临床医生在选择经验性治疗时应严格评估既往抗生素暴露情况。